The human gut microbiome is associated with a wide range of diseases; yet, the
mechanisms these microbes use to influence human health are not fully understood. Protein …

The gut microbiota plays a significant role in the pathogenesis of both forms of inflammatory
bowel disease (IBD), namely Crohn's disease (CD) and ulcerative colitis (UC). While …

The past decade has witnessed a revolution in cancer treatment by shifting from
conventional therapies to immune checkpoint inhibitors (ICIs). These immunotherapies …

Many drugs can perturb the gut microbiome, potentially leading to negative health
consequences. However, mechanisms of most microorganism–drug responses have not …

Probiotic and engineered microbe-based therapeutics are an emerging class of
pharmaceutical agents. They represent a promising strategy for treating various chronic and …

Fibrosis is characterized by a proliferation of fibroblasts and excessive extracellular matrix
following chronic inflammation, and this replacement of organ tissue with fibrotic tissue …

IBD, including ulcerative colitis and Crohn's disease, is a chronic and debilitating
gastrointestinal disorder that affects millions of people worldwide. Research on IBD has …

In metagenomics, the pool of uncharacterized microbial enzymes presents a challenge for
functional annotation. Among these, carbohydrate-active enzymes (CAZymes) stand out due …

Inflammatory bowel disease (IBD) is associated with dysbiotic microbiomes. However,
whether microbiomes of family members of IBD patients harbour microbial disease …

[目的] 初步研究饲粮添加猪源罗伊氏乳杆菌对断奶仔猪肠道细胞外基质(Extracellular matrix,
ECM) 表达的影响, 为猪源罗伊氏乳杆菌在畜牧业中的推广应用提供参考.[方法] 选取21 …